Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

ABC-X Clinical Trial - Melanoma Institute Australia

Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma

Cureus, Aggressive Stereotactic Radiosurgery Coupled With Immune and Targeted Therapy for Recurrent Melanoma Brain Metastases: A Case Report and Literature Review

Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis - ScienceDirect

Opdualag Approved to Treat Advanced Melanoma - NCI

Addition of nivolumab, ipilimumab to chemotherapy extends OS in NSCLC with brain metastases

Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives

Evolving impact of long-term survival results on metastatic melanoma treatment

Actualizaciòn en el tratamiento de metàstasis cerebrales por melanoma

Ipilimumab - Wikipedia

IJMS, Free Full-Text

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity, Journal for ImmunoTherapy of Cancer

A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence